John C. Tilton
Impact in
- Virology top 0.5%
- HIV Research and Treatment
- Infectious Diseases top 1%
- HIV/AIDS drug development and treatment
- COVID-19 Clinical Research Studies
- HIV/AIDS Research and Interventions
Papers in
- Virology 28
- HIV Research and Treatment 28
-
- HIV/AIDS drug development and treatment 17
- HIV/AIDS Research and Interventions 7
- SARS-CoV-2 and COVID-19 Research 3
- Co-authors
- Robert W. DomsCraig B. WilenMark ConnorsEric O. LongCarsten WatzlPhilipp EissmannJulia A. MetcalfClaire W. Hallahan
- Journals
- Journal of Virology (11 papers)Viruses (3 papers)Retrovirology (2 papers)Antiviral Research (2 papers)Current HIV/AIDS Reports (1 paper)
- Partner nations
- United StatesCanadaAustralia
In The Last Decade
John C. Tilton
35 papers receiving 2.4k citations
Hit Papers
Peers
Comparison fields: 5 of 119
- Virology 1.2k
- Infectious Diseases 969
- Immunology 907
- Hepatology 153
- Epidemiology 468
Countries citing papers authored by John C. Tilton
This map shows the geographic impact of John C. Tilton's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by John C. Tilton with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites John C. Tilton more than expected).
Fields of papers citing papers by John C. Tilton
This network shows the impact of papers produced by John C. Tilton. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by John C. Tilton. The network helps show where John C. Tilton may publish in the future.
Co-authors
The 25 scholars most cited alongside John C. Tilton, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2024 | 1 | |
| 2 | COVID-19 and Cardiovascular Disease Hit paper breakdown → | 2021 | 251 |
| 3 | 2021 | 55 | |
| 4 | 2021 | 3 | |
| 5 | 2020 | 96 | |
| 6 | 2020 | 8 | |
| 7 | 2018 | 9 | |
| 8 | 2017 | 43 | |
| 9 | 2017 | 20 | |
| 10 | 2017 | 9 | |
| 11 | 2015 | 4 | |
| 12 | 2014 | 41 | |
| 13 | 2013 | 102 | |
| 14 | 2013 | 13 | |
| 15 | 2011 | 163 | |
| 16 | 2010 | 44 | |
| 17 | 2009 | 163 | |
| 18 | 2008 | 70 | |
| 19 | 2006 | 6 | |
| 20 | 2006 | 64 |
About John C. Tilton
John C. Tilton is a scholar working on Virology, Infectious Diseases, Immunology, Hepatology and Epidemiology, having authored 35 papers that have together received 2.4k indexed citations. Recurring topics across this work include HIV Research and Treatment (28 papers), HIV/AIDS drug development and treatment (17 papers), Immune Cell Function and Interaction (16 papers), HIV/AIDS Research and Interventions (7 papers), T-cell and B-cell Immunology (6 papers), Mosquito-borne diseases and control (5 papers), Cytomegalovirus and herpesvirus research (5 papers) and SARS-CoV-2 and COVID-19 Research (3 papers). The work is most often cited by research in Virology (1.2k citations), Infectious Diseases (969 citations), Immunology (907 citations), Hepatology (153 citations) and Epidemiology (468 citations). John C. Tilton has collaborated with scholars based in United States, Canada and Australia. Frequent co-authors include Robert W. Doms, Craig B. Wilen, Mark Connors, Eric O. Long, Carsten Watzl, Philipp Eissmann, Julia A. Metcalf, Claire W. Hallahan, Alison J. Johnson and Scott J. Cameron. Their work appears in journals such as Journal of Virology, Viruses, Retrovirology, Antiviral Research and Current HIV/AIDS Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.